Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NMIBC”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06800963
What this trial is testing

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

Who this might be right for
NMIBC
ImmunityBio, Inc. 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588179
What this trial is testing

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

Who this might be right for
NMIBC
Fudan University 58
Large-scale testing (Phase 3)Looking for participantsNCT06929286
What this trial is testing

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Memorial Sloan Kettering Cancer Center 125
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Active Not RecruitingNCT06253845
What this trial is testing

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Who this might be right for
Non-muscle Invasive Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT04172675
What this trial is testing

Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 107
Very early researchStudy completedNCT04897763
What this trial is testing

Assessment of Safety, Tolerability, Radiation Dosimetry, Imaging Properties of 89Zr-girentuximab in Patients With NMIBC

Who this might be right for
Bladder Cancer
Institut Cancerologie de l'Ouest 6
Testing effectiveness (Phase 2)Looking for participantsNCT07122414
What this trial is testing

Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Suzhou Forlong Biotechnology Co., Ltd 80
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Not applicableUnknownNCT05176145
What this trial is testing

Demonstration of the Medical Interest of the VisioCyt® Artificial Intelligence Test

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
Vitadx 400
Large-scale testing (Phase 3)Looking for participantsNCT06241755
What this trial is testing

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Chengdu CoenBiotech Co., Ltd 412
Large-scale testing (Phase 3)Study completedNCT02773849
What this trial is testing

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Superficial Bladder Cancer
Ferring Pharmaceuticals 157
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06255964
What this trial is testing

IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
SUNHO（China）BioPharmaceutical CO., Ltd. 236
Not applicableAvailableNCT06810141
What this trial is testing

ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

Who this might be right for
NMIBC
ImmunityBio, Inc.
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Large-scale testing (Phase 3)Ended earlyNCT04688931
What this trial is testing

UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 282
Not applicableNot Yet RecruitingNCT06324058
What this trial is testing

Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC

Who this might be right for
Bladder Cancer
Huashan Hospital 190
Not applicableUnknownNCT04644835
What this trial is testing

Low Energy Shock Wave Therapy and Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 50
Post-approval studies (Phase 4)Study completedNCT06767982
What this trial is testing

Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

Who this might be right for
Non Muscle Invasive Bladder Cancer
Ankara University 160
Early research (Phase 1)Study completedNCT03854721
What this trial is testing

Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Urinary Bladder
Vaxiion Therapeutics 6
Load More Results